Dean R - Search Results

1

African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis.

Yazdanfar M, Zepeda J, Dean R, Wu J, Levy C, Goldberg D, Lammert C, Prenner S, Reddy KR, Pratt D, Forman L, Assis DN, Lytvyak E, Montano-Loza AJ, Gordon SC, Carey EJ, Ahn J, Schlansky B, Korzenik J, Karagozian R, Hameed B, Chandna S, Yu L, Bowlus CL. Yazdanfar M, et al. Among authors: dean r. Hepatol Commun. 2024 Jan 29;8(2):e0366. doi: 10.1097/HC9.0000000000000366. eCollection 2024 Feb 1. Hepatol Commun. 2024. PMID: 38285883 Free PMC article.

2

Glucose-induced tyrosine phosphorylation of p125 in beta cells and pancreatic islets. A novel proximal signal in insulin secretion.

Konrad RJ, Dean RM, Young RA, Billings PC, Wolf BA. Konrad RJ, et al. Among authors: dean rm. J Biol Chem. 1996 Sep 27;271(39):24179-86. doi: 10.1074/jbc.271.39.24179. J Biol Chem. 1996. PMID: 8798659 Free article.

3

Outcomes of Primary Anterior Cruciate Ligament (ACL) Repair for Proximal Tears: A Systematic Review and Meta-Analysis.

Braithwaite C, Hafen TJ, Dean R, Lebaschi A, Guettler J, Bicos J. Braithwaite C, et al. Among authors: dean r. Cureus. 2024 Apr 27;16(4):e59124. doi: 10.7759/cureus.59124. eCollection 2024 Apr. Cureus. 2024. PMID: 38803739 Free PMC article. Review.

4

Prospective evaluation of the impact of multi-channel studies on treatment outcomes in children with sleep disordered breathing.

Yanney M, Rowbotham N, Ng C, Zulkifli M, Shehata A, Chidambaram A, Tsirevelou P, Fergie N, Thakkar P, Crookes E, Dean R, Prayle A. Yanney M, et al. Among authors: dean r. Sleep Med X. 2024 Apr 18;7:100111. doi: 10.1016/j.sleepx.2024.100111. eCollection 2024 Dec. Sleep Med X. 2024. PMID: 38800098 Free PMC article.

5

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.

Patel AA, Yoon JJ, Johnston H, Davidson MB, Shallis RM, Chen EC, Burkart M, Oh TS, Iyer SG, Madarang E, Muthiah C, Gross I, Dean R, Kassner J, Viswabandya A, Madero-Marroquin R, Rampal RK, Guru Murthy GS, Bradley TJ, Abaza Y, Garcia JS, Gupta V, Pettit KM, Cursio JF, Odenike O. Patel AA, et al. Among authors: dean r. Blood Adv. 2024 May 13:bloodadvances.2024012880. doi: 10.1182/bloodadvances.2024012880. Online ahead of print. Blood Adv. 2024. PMID: 38739724

6

Horse owner perceptions of equine veterinary nursing roles in the United Kingdom.

Pritchard P, Robinson N, Saul A, Shrubb J, Stavisky J, Dean R. Pritchard P, et al. Among authors: dean r. Vet Rec. 2024 May 4;194(9):e4148. doi: 10.1002/vetr.4148. Epub 2024 Apr 24. Vet Rec. 2024. PMID: 38659211

7

BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

Stuver R, Mian A, Brown S, Devlin S, Caimi PF, Chinapen S, Dahi P, Dean R, Epstein-Peterson ZD, Hill B, Horwitz SM, Lahoud O, Lin R, Moskowitz AJ, Sauter C, Shah G, Winter A, Jagadeesh D, Scordo M. Stuver R, et al. Among authors: dean r. Am J Hematol. 2024 Jun;99(6):1180-1183. doi: 10.1002/ajh.27291. Epub 2024 Mar 25. Am J Hematol. 2024. PMID: 38526002

8

Comparison of N···I and N···O Halogen Bonds in Organoiodine Cocrystals of Heterocyclic Aromatic Diazine Mono-N-oxides.

Padgett CW, Dean R, Cobb A, Miller A, Goetz A, Bailey S, Hillis K, McMillen C, Toney S, Guillet GL, Lynch W, Pennington WT. Padgett CW, et al. Among authors: dean r. Cryst Growth Des. 2024 Mar 5;24(6):2425-2438. doi: 10.1021/acs.cgd.3c01344. eCollection 2024 Mar 20. Cryst Growth Des. 2024. PMID: 38525103 Free PMC article.

9

Bioactive and Bioinductive Implants Are Increasingly Used in Orthopaedic Sports Medicine but Adequately Controlled Studies Are Needed: A Scoping Review.

Lauck BJ, Reynolds AW, van der List JP, Deivert K, Dean RS, Trasolini NA, Waterman BR. Lauck BJ, et al. Among authors: dean rs. Arthroscopy. 2024 Mar 10:S0749-8063(24)00176-2. doi: 10.1016/j.arthro.2024.03.003. Online ahead of print. Arthroscopy. 2024. PMID: 38467172 Review.

10

Lenalidomide, rituximab (R²), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma.

Hill BT, Chen Y, Jagadeesh D, Dean R, Koc O, Boughan K, Cooper B, Pohlman B, Caimi P, Smith MR. Hill BT, et al. Among authors: dean r. Leuk Lymphoma. 2024 Jun;65(6):768-773. doi: 10.1080/10428194.2024.2325636. Epub 2024 Mar 8. Leuk Lymphoma. 2024. PMID: 38456694 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,697 results

Search Page